Cargando…
Targeting Tumor Microenvironment Akt Signaling Represents a Potential Therapeutic Strategy for Aggressive Thyroid Cancer
Effects of the tumor microenvironment (TME) stromal cells on progression in thyroid cancer are largely unexplored. Elucidating the effects and underlying mechanisms may facilitate the development of targeting therapy for aggressive cases of this disease. In this study, we investigated the impact of...
Autores principales: | Mirshahidi, Saied, Yuan, Isabella J., Simental, Alfred, Lee, Steve C., Peterson, Nathaniel R., Andrade Filho, Pedro A., Murry, Thomas, Duerksen-Hughes, Penelope, Yuan, Xiangpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049397/ https://www.ncbi.nlm.nih.gov/pubmed/36982542 http://dx.doi.org/10.3390/ijms24065471 |
Ejemplares similares
-
Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy
por: Hu, Jinwei, et al.
Publicado: (2021) -
Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management
por: Castillo, Dani Ran, et al.
Publicado: (2023) -
Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest
por: Shouse, Geoffrey, et al.
Publicado: (2016) -
Modulation of Apoptotic Pathways by Human Papillomaviruses (HPV): Mechanisms and Implications for Therapy
por: Yuan, Chung-Hsiang, et al.
Publicado: (2012) -
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
por: Chitsike, Lennox, et al.
Publicado: (2021)